Copy number alterations unmasked as enhancer hijackers (original) (raw)
- News & Views
- Published: 28 December 2016
Nature Genetics volume 49, pages 5–6 (2017)Cite this article
- 7386 Accesses
- 28 Citations
- 93 Altmetric
- Metrics details
Subjects
Our understanding of how DNA copy number changes contribute to disease, including cancer, has to a large degree been focused on the changes in gene dosage that they generate and has neglected the effects of the DNA rearrangements that lead to their formation. A new study reports an innovative analytical framework for copy number alterations that are oncogenic primarily owing to the genomic rearrangements that underlie them.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Figure 1: Oncogenic rearrangement topologies that rely on changes in relative placement of genes near regulatory elements rather than simple changes in gene dosage.
References
- Zack, T.I. et al. Nat. Genet. 45, 1134–1140 (2013).
Article CAS Google Scholar - Weischenfeldt, J. et al. Nat. Genet. 49, 65–74 (2017).
Article CAS Google Scholar - Wong, A.J. et al. Proc. Natl. Acad. Sci. USA 89, 2965–2969 (1992).
Article CAS Google Scholar - Ong, C.-T. & Corces, V.G. Nat. Rev. Genet. 12, 283–293 (2011).
Article CAS Google Scholar - Hnisz, D., Day, D.S. & Young, R.A. Cell 167, 1188–1200 (2016).
Article CAS Google Scholar - Northcott, P.A. et al. Nature 511, 428–434 (2014).
Article CAS Google Scholar - Battey, J. et al. Cell 34, 779–787 (1983).
Article CAS Google Scholar - Bandopadhayay, P. et al. Nat. Genet. 48, 273–282 (2016).
- Tomlins, S.A. et al. Science 310, 644–648 (2005).
Article CAS Google Scholar - Gröschel, S. et al. Cell 157, 369–381 (2014).
Article Google Scholar - Zhang, X. et al. Nat. Genet. 48, 176–182 (2016).
Article CAS Google Scholar - Hnisz, D. et al. Science 351, 1454–1458 (2016).
Article CAS Google Scholar - Cancer Genome Atlas Network. Nature 487, 330–337 (2012).
- Stephens, P.J. et al. Cell 144, 27–40 (2011).
Article CAS Google Scholar - Baca, S.C. et al. Cell 153, 666–677 (2013).
Article CAS Google Scholar
Author information
Authors and Affiliations
- Rameen Beroukhim, Xiaoyang Zhang and Matthew Meyerson are at the Dana-Farber Cancer Institute, the Broad Institute of Harvard and MIT, and Harvard Medical School, Boston, Massachusetts, USA.,
Rameen Beroukhim, Xiaoyang Zhang & Matthew Meyerson
Authors
- Rameen Beroukhim
You can also search for this author inPubMed Google Scholar - Xiaoyang Zhang
You can also search for this author inPubMed Google Scholar - Matthew Meyerson
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toMatthew Meyerson.
Ethics declarations
Competing interests
R.B. receives research support from and is a consultant for Novartis. M.M. receives research support from Bayer and is a founding advisor of Foundation Medicine, for which he was previously a consultant and in which he previously held equity.
Rights and permissions
About this article
Cite this article
Beroukhim, R., Zhang, X. & Meyerson, M. Copy number alterations unmasked as enhancer hijackers.Nat Genet 49, 5–6 (2017). https://doi.org/10.1038/ng.3754
- Published: 28 December 2016
- Issue Date: January 2017
- DOI: https://doi.org/10.1038/ng.3754